<DOC>
	<DOCNO>NCT01436253</DOCNO>
	<brief_summary>This study do see whether dietary medicinal measure compliant hyperlipidemia treatment guideline result achieve target lipid value evaluate total risk cardiovascular disease study participant reach satisfactory lipid level current hypolipemic therapy .</brief_summary>
	<brief_title>Study Lipid Control Hyperlipidemic Participants ( MK-0653-179 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Inclusion criterion : Hyperlipidemic On therapy hyperlipidemia &gt; =3 month without achieve target lipid value Exclusion criterion : Hypersensitivity intolerance hypolipemics Significant myopathy rhabdomiolysis probably cause hypolipemics Uncontrolled endocrine metabolic disease know affect lipid lipoprotein value ( example , hypothyroidism hyperthyroidism )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>